Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Nested culture method improves detection of Fusobacterium from stool in patients with ulcerative colitis.

Yukawa T, Ohkusa T, Shibuya T, Tsukinaga S, Mitobe J, Takakura K, Takahara A, Odahara S, Matsudaira H, Nagatsuma K, Kitahara T, Kajihara M, Uchiyama K, Arakawa H, Koido S, Tajiri H.

Jpn J Infect Dis. 2013;66(2):109-14.

2.

Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up.

Ohkusa T, Nomura T, Terai T, Miwa H, Kobayashi O, Hojo M, Takei Y, Ogihara T, Hirai S, Okayasu I, Sato N.

Scand J Gastroenterol. 2005 Nov;40(11):1334-42.

PMID:
16334443
3.

Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.

Koido S, Ohkusa T, Kajiura T, Shinozaki J, Suzuki M, Saito K, Takakura K, Tsukinaga S, Odahara S, Yukawa T, Mitobe J, Kajihara M, Uchiyama K, Arakawa H, Tajiri H.

PLoS One. 2014 Jan 29;9(1):e86702. doi: 10.1371/journal.pone.0086702.

4.
5.

Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy.

Nomura T, Ohkusa T, Okayasu I, Yoshida T, Sakamoto M, Hayashi H, Benno Y, Hirai S, Hojo M, Kobayashi O, Terai T, Miwa H, Takei Y, Ogihara T, Sato N.

Aliment Pharmacol Ther. 2005 Apr 15;21(8):1017-27.

6.

Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody.

Ohkusa T, Sato N, Ogihara T, Morita K, Ogawa M, Okayasu I.

J Gastroenterol Hepatol. 2002 Aug;17(8):849-53.

PMID:
12164960
7.

Rifampin-blood-agar as a selective medium for the isolation of certain anaerobic bacteria.

Sutter VL, Sugihara PT, Finegold SM.

Appl Microbiol. 1971 Nov;22(5):777-80.

8.

Seroprevalence of Fusobacterium varium in ulcerative colitis patients in Japan.

Minami M, Ando T, Okamoto A, Sasaki N, Ohkura T, Torii K, Hasegawa T, Ohta M, Goto H.

FEMS Immunol Med Microbiol. 2009 Jun;56(1):67-72.

9.

Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial.

Ohkusa T, Kato K, Terao S, Chiba T, Mabe K, Murakami K, Mizokami Y, Sugiyama T, Yanaka A, Takeuchi Y, Yamato S, Yokoyama T, Okayasu I, Watanabe S, Tajiri H, Sato N; Japan UC Antibiotic Therapy Study Group..

Am J Gastroenterol. 2010 Aug;105(8):1820-9. doi: 10.1038/ajg.2010.84.

PMID:
20216533
10.

Fusobacterium detected in colonic biopsy and clinicopathological features of ulcerative colitis in Japan.

Tahara T, Shibata T, Kawamura T, Okubo M, Ichikawa Y, Sumi K, Miyata M, Ishizuka T, Nakamura M, Nagasaka M, Nakagawa Y, Ohmiya N, Arisawa T, Hirata I.

Dig Dis Sci. 2015 Jan;60(1):205-10. doi: 10.1007/s10620-014-3316-y.

PMID:
25102986
11.

Fusobacterium varium in ulcerative colitis: is it population-based?

Allen-Vercoe E.

Dig Dis Sci. 2015 Jan;60(1):7-8. doi: 10.1007/s10620-014-3390-1. No abstract available.

PMID:
25311584
12.

A selective medium for Fusobacterium spp.

Brazier JS, Citron DM, Goldstein EJ.

J Appl Bacteriol. 1991 Oct;71(4):343-6.

PMID:
1960109
13.

Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis.

Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y.

Inflamm Bowel Dis. 2007 Aug;13(8):955-62.

PMID:
17455205
14.
15.

Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital.

Luna RA, Boyanton BL Jr, Mehta S, Courtney EM, Webb CR, Revell PA, Versalovic J.

J Clin Microbiol. 2011 Mar;49(3):851-7. doi: 10.1128/JCM.01983-10.

16.

Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis.

Ohkusa T, Yoshida T, Sato N, Watanabe S, Tajiri H, Okayasu I.

J Med Microbiol. 2009 May;58(Pt 5):535-45. doi: 10.1099/jmm.0.005801-0.

17.

Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.

Nemoto H, Kataoka K, Ishikawa H, Ikata K, Arimochi H, Iwasaki T, Ohnishi Y, Kuwahara T, Yasutomo K.

Dig Dis Sci. 2012 Nov;57(11):2955-64. doi: 10.1007/s10620-012-2236-y.

PMID:
22623042
18.

Medium for selective isolation of Fusobacterium nucleatum from human periodontal pockets.

Walker CB, Ratliff D, Muller D, Mandell R, Socransky SS.

J Clin Microbiol. 1979 Dec;10(6):844-9.

19.

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A.

BMC Gastroenterol. 2010 Nov 12;10:134. doi: 10.1186/1471-230X-10-134.

20.

Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.

Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, Furrie E, Macfarlane S.

Gut. 2004 Apr;53(4):523-9.

Items per page

Supplemental Content

Support Center